Absorption |
Blood-Brain Barrier | BBB+ | 0.8973 |
Human Intestinal Absorption | HIA+ | 0.9755 |
Caco-2 Permeability | Caco2- | 0.6133 |
P-glycoprotein Substrate | Non-substrate | 0.6539 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8994 |
Non-inhibitor | 0.9397 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8636 |
Distribution |
Subcellular localization | Mitochondria | 0.6738 |
Metabolism |
CYP450 2C9 Substrate | Substrate | 0.6723 |
CYP450 2D6 Substrate | Non-substrate | 0.8845 |
CYP450 3A4 Substrate | Non-substrate | 0.7545 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8944 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9464 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9040 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8562 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6846 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9046 |
Non-inhibitor | 0.9154 |
AMES Toxicity | Non AMES toxic | 0.9232 |
Carcinogens | Non-carcinogens | 0.8713 |
Fish Toxicity | High FHMT | 0.9857 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9229 |
Honey Bee Toxicity | Low HBT | 0.7833 |
Biodegradation | Not ready biodegradable | 0.9046 |
Acute Oral Toxicity | III | 0.8090 |
Carcinogenicity (Three-class) | Non-required | 0.6750 |